WILCO startup cluster December 5, 2018 tokyonne News HEPHAISTOS-Pharma was selected by WILCO startup cluster to obtain capital loans and increase our own funds. Share ThisTweetShareShareEmail Related Posts European Grant HEPHAISTOS-Pharma obtained a European Grant for its development program of immuno-stimulators. The Inno-Boost-LPS project aims… University Paris Saclay HEPHAISTOS-Pharma was present at the Event organized by the University Paris Saclay for its collaborating… Orphan Drug Designation The European Medicines Agency (EMA) has granted Orphan Drug Designation to ONCO-Boost (HEPHAISTOS-Pharma) as treatment…
European Grant HEPHAISTOS-Pharma obtained a European Grant for its development program of immuno-stimulators. The Inno-Boost-LPS project aims…
University Paris Saclay HEPHAISTOS-Pharma was present at the Event organized by the University Paris Saclay for its collaborating…
Orphan Drug Designation The European Medicines Agency (EMA) has granted Orphan Drug Designation to ONCO-Boost (HEPHAISTOS-Pharma) as treatment…